GL1X · GenesisL1 explorer

MolNFT v1 · #53456 · protein

Complex of human dihydroorotate dehydrogenase with the inhibitor 221290

2WV8 · Dihydroorotate dehydrogenase, mitochondrial: “Complex of human dihydroorotate dehydrogenase with the inhibitor 221290”. X-ray diffraction, 5 ligands (FMN, ORO, VGN), 4 pockets (best druggability 0.83). MolNFT v1 #53456 on GenesisL1…

PDB
2WV8
Type
protein
Length
365 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Dihydroorotate dehydrogenase, mitochondrial
EC
1.3.5.2
UniProt
Q02127
Ligands
FMN, ORO, VGN, DDQ, SO4
Pockets
4 · best druggability 0.83

Structure

x-ray diffraction · 1 distinct chain · 46% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADihydroorotate dehydrogenase, mitochondrial (EC 1.3.5.2)protein36546% helix, 16% strandQ02127

Ligands and binding sites

  • FMN · Flavin mononucleotide · ligand · chains A
  • ORO · Orotic acid · ligand · chains A
  • VGN · 2-acetamido-5-(4-phenylphenyl)benzoic acid · ligand · chains A
  • DDQ · Decylamine-N,N-dimethyl-N-oxide · ligand · chains A
  • SO4 · Sulfate ion · ion · chains A
  • ACT · Acetate ion · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14020.830.9158FMN, ORO, VGN
2930.440.7927empty
3890.440.8018empty
41000.430.7919empty

Compared structures

  • 2WV8 · Complex of human dihydroorotate dehydrogenase with the inhibitor 221290 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.